Abstract Details

Title A Clinical Precision Medicine Approach Reduces Alzheimer’s, Dementia and Vascular Risk and Improves Cognition: A Prospective Cohort Study

Topic Aging and Dementia

Presentation(s) P6 - (-)

Poster/Presentation
Number 085

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Richard S. Isaacson, MD, FAAN PRESENTER	Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Emily Caesar	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Lisa Mosconi	No disclosure on file
	No disclosure on file
	No disclosure on file
Matthew W. Schelke, MD (New York Presbyterian Hospital, Columbia)	Dr. Schelke has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Alon Seifan, MD (Cognitive Neurology Consultants, Inc. dba the Neuro Well)	Dr. Seifan has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Science Officer with HB Biotech.

��ɫ��